TW201031757A - Methods and systems for identifying polynucleotide sequences with translational self-cleavage activity - Google Patents

Methods and systems for identifying polynucleotide sequences with translational self-cleavage activity Download PDF

Info

Publication number
TW201031757A
TW201031757A TW098105161A TW98105161A TW201031757A TW 201031757 A TW201031757 A TW 201031757A TW 098105161 A TW098105161 A TW 098105161A TW 98105161 A TW98105161 A TW 98105161A TW 201031757 A TW201031757 A TW 201031757A
Authority
TW
Taiwan
Prior art keywords
sequence
candidate sequence
protein
similar
candidate
Prior art date
Application number
TW098105161A
Other languages
Chinese (zh)
Other versions
TWI412594B (en
Inventor
Tzong-Yuan Wu
Chung-Hsiung Wang
Yu-Jie Chen
Chao-Yi Teng
Ying-Ju Chen
Original Assignee
Univ Chung Yuan Christian
Univ Nat Taiwan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Chung Yuan Christian, Univ Nat Taiwan filed Critical Univ Chung Yuan Christian
Priority to TW098105161A priority Critical patent/TWI412594B/en
Publication of TW201031757A publication Critical patent/TW201031757A/en
Application granted granted Critical
Publication of TWI412594B publication Critical patent/TWI412594B/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Provided herein are methods and systems for identifying 2A-like sequences with translational self-cleavage activity in an insect expression system.

Description

201031757 六、發明說明: 【發明所屬之技術領域】 本發明係關於用來鑑別具有轉譯層級自我切割 活性的多核苷酸之方法和/或系統。詳古 ,.° 叮σ ’本發明 係關於利用昆蟲表現系統中的螢光分佈模式來鑑別 出具有類似2 A序列的多核普酸之方法和/或系統。 【先前技術】 雙-順反子或多-順反子表現載體具有廣泛的用 途’例如可用來製造非同源性寡聚蛋白、基因治療、 細胞組織工程等等,且容許以等莫耳數的方'式 (equimolar)來表現不同的標的蛋白。 目前用來創造多-順反子表現載體的方法包括使 用核醋體内部進入位址(internal rib〇some entl*y Site, IRES)、多個啟動子和有或無經由細胞蛋白酶位置進 行連接的融合蛋白。但是,這些方法在實際應用上 都遇到一些困難。 IRES本身相當大,因此僅有少數載體可資運 用’例如病毒載體或含有跳躍子之類的載體。此外, 基因在轉錄物上的排列順序也可能使下游基因的表 現量大幅縮減(Hennecke,M_, et al.,(2001) A/ac/e/c 如/办201031757 VI. Description of the Invention: [Technical Field of the Invention] The present invention relates to a method and/or system for identifying a polynucleotide having a translation level self-cleaving activity. DETAILED DESCRIPTION OF THE INVENTION The present invention relates to methods and/or systems for identifying polynucleic acid having a similar 2 A sequence using a fluorescence distribution pattern in an insect expression system. [Prior Art] Double-cistronic or poly-cistronic expression vectors have a wide range of uses', for example, can be used to make non-homologous oligomeric proteins, gene therapy, cell tissue engineering, etc., and allow for a molar number. The square 'equimolar' to represent different target proteins. Current methods for creating poly-cistronic expression vectors include the use of internal rib〇some entl*y Site (IRES), multiple promoters, and linkages with or without cellular protease positions. Fusion protein. However, these methods have encountered some difficulties in practical applications. The IRES itself is quite large, so only a few vectors can be used, such as viral vectors or vectors containing jumpers. In addition, the order in which genes are transcribed may also significantly reduce the performance of downstream genes (Hennecke, M_, et al., (2001) A/ac/e/c.

Res. 29: 3327-3334; Fux, C. et alM (2004) BiotechnoL Bioeng. 86: 174-87) 〇 製造融合蛋白則可能會因蛋白質折疊不當或細 胞傳送機制導致融合蛋白質功能不彰。而使用多個 啟動子則會使報導基因與標的基因表現間的速接關 201031757 係變得較不緊密(Gaken,丄,et al·,(2000) Gene 77?er· 7: 1979-1985; de Felipe, P., (2004) Genet Vacc. Then 2: 1-12) ° 最近提出來的方法涉及利用口蹄疫病毒(FMDV) 的2A或類似-2A的順式作用水解酶元件(CHYSEL) 來創造出可由同一轉錄物中產生多個蛋白質的多-順反子表現載體(Szymczak, A. L.,et al., (2004) A/ai. Biotechnol. 22: 589-594; de Felipe, P., et al., (1999) Gene Then 6: 198-208;日 Amrani,A” et al_, (2004) P/ani P/7ys/o/. 135: 16-24)。許多病毒可編碼產生多個可由2A或類似-2A序列位 ❹置被切開成為單獨蛋白產物的蛋白質(Palmenberg, A. C.,et al·,(1992) Wro/ogry 190: 754-762; Donnelly, M_ L. L·,et al., (2001) J. Gen. Virol. 82: 1027-1041; Ryan, M. D. et al., (1991) J. Ge/i V/ra/· 72: 2727-2732)。這種類似-2A序列中含有 Asp-Va丨川e-Glu-X-Asn-Pro-Gly-Pro表位,可自我切斷甘胺 酸與辅胺酸間的連接(Palmenberg,A. C. (1990) vAnmy. Rev: Microbiol. 44: 603-623; Hahn, H. and Palmenberg, A. C., (1996) J. V/ro/. 70: 6870-6875)。這種切開機制可能是來自核醣 體跳躍機制所致,使得核醣體活性受到類似-2A序 • 列的修整,而能防止在甘胺酸與輔胺酸間產生胜肽 鍵。因此,位於類似-2A序列上游的蛋白質將會被 釋出,同時繼績轉譯其下游基因(de Felipe, P. et al., (2003) J. Biol. Chem. 278: 11441-11448; Donnelly, M. L. L., etal., (2001) J. Gen. 82: 1013 - 1025)。 大部分的類似-2A序列都是在會感染哺乳動物 細胞的病毒上發現的,只有少數的類似-2A序列是 從昆蟲病毒中找到的。此外,在昆蟲表現系統中, _ 目前已知的病毒類似-2A序列在mRNA轉譯斯間仍 無法被完全切斷,導致其個別上游與下游標的胜肽 201031757 ,或蛋白質無法被充分表現。 因此’亟需荨找一種士入 類似-2A序列,以提高兮凡王我切斷之改良的 生的上游和下游蛋白質$斤歹J所分別編碼產 種有效且容易使用的方 ’供- 類似-2Λ序列,此方、予无來找呼潛在的 .^ ^ J 法和/或系統是透過在昆声备μ 中表現出來的獨特勞光分佈蟲系統 員似2Α序列疋否為欲求的類似_2α序 標,因而能解決目俞春兑从 的才田 解决目别先别技術中存在的難題。 【發明内容】 昆蟲表現糸統中用來 發核醣體跳躍的多核 如所述’本發明特徵為在一 鑑別出可於mRNA轉譯期間誘 苷酸之方法和/或系統。 甘因此,本發明目地之一在於提供一種用來在— 昆蟲系統中鑑別出一類似_2A序列的方法。該方法 特徵在於包含以下步驟: (a)以一包含以下序列的重組載體轉染一昆蟲 細胞: 一啟動子; 一第一多核苷酸,其係可操作地連結到該啟 動子並編碼產生一分泌性蛋白; 一候選序列’其係可操作地連錄到該第一多 核苷酸;及 一第二多核苦酸,其係可操作地連結到該候 選序列並編碼產生一螢光蛋白;和 201031757 • (b)依據該昆蟲細胞所表現出來的一勞光模式 來決定該候選序列是否具有一轉譯層級自我切割 f生如果螢光疋均勻地分佈在該昆蟲細胞内(包括細 胞核)’則該候選序列是該類似_2a序列;如果螢光 呈現一甜甜圈形狀且侷限在細胞梭外或是被分泌到 細胞外介質中,則該候選序列不是該類似_2A序列。 、在一較佳實施方式中’該候選序列是分離自榕樹 透翅毒蛾類小病毒(Perina nuda Picoma-like virusRes. 29: 3327-3334; Fux, C. et alM (2004) BiotechnoL Bioeng. 86: 174-87) 〇 The production of fusion proteins may result in poor function of the fusion protein due to improper protein folding or cell transport mechanisms. The use of multiple promoters makes the fast-linking between the reporter gene and the target gene expression 201031757 less tight (Gaken, 丄, et al., (2000) Gene 77?er· 7: 1979-1985; De Felipe, P., (2004) Genet Vacc. Then 2: 1-12) ° The recently proposed method involves the creation of 2A or similar-2A cis-acting hydrolase elements (CHYSEL) using foot-and-mouth disease virus (FMDV). A multi-cistronic expression vector that produces multiple proteins from the same transcript (Szymczak, AL, et al., (2004) A/ai. Biotechnol. 22: 589-594; de Felipe, P., et al (1999) Gene Then 6: 198-208; Amrani, A” et al_, (2004) P/ani P/7ys/o/. 135: 16-24). Many viruses can be encoded to produce multiple 2A Or a protein similar to the -2A sequence that is cleaved into a separate protein product (Palmenberg, AC, et al., (1992) Wro/ogry 190: 754-762; Donnelly, M_L. L., et al., ( 2001) J. Gen. Virol. 82: 1027-1041; Ryan, MD et al., (1991) J. Ge/i V/ra/· 72: 2727-2732). This similar -2A sequence contains Asp -Va 丨川 e-Glu-X-Asn-Pro-Gly-Pro epitope, I cut the connection between glycine and arginine (Palmenberg, AC (1990) vAnmy. Rev: Microbiol. 44: 603-623; Hahn, H. and Palmenberg, AC, (1996) J. V/ro/ 70: 6870-6875). This incision mechanism may be caused by a ribosome hopping mechanism, which causes the ribosome activity to be trimmed by a similar -2A sequence, which prevents the production of glycine and auxin. Peptide bonds. Therefore, proteins located upstream of the -2A sequence will be released and their downstream genes will be translated (de Felipe, P. et al., (2003) J. Biol. Chem. 278: 11441-11448 Donnelly, MLL, et al., (2001) J. Gen. 82: 1013 - 1025). Most of the similar -2A sequences are found on viruses that infect mammalian cells, and only a few similar -2A sequences are found in insect viruses. In addition, in the insect expression system, the currently known virus-like-2A sequence is still not completely cleaved between mRNA translations, resulting in its individual upstream and downstream target peptides 201031757, or the protein cannot be fully expressed. Therefore, it is not necessary to find a kind of similar--2A sequence to improve the improved upstream and downstream protein of the scorpion I cut off. The code is effective and easy to use. -2Λ sequence, this side, no way to find potential. ^ ^ J method and / or system is through the unique sound of the sound in the sound of the sound of the μ system, such as 2 sequences, whether it is similar to the desire The _2α sequence standard can solve the problem that the Yu Yuchun has to solve the problem in the field. SUMMARY OF THE INVENTION Insects exhibit multinuclei for use in ribosomal hopping in the genus. The invention is characterized by a method and/or system for identifying a bacterium that can be transcribed during mRNA translation. Thus, one of the objects of the present invention is to provide a method for identifying a similar _2A sequence in an insect system. The method comprises the steps of: (a) transfecting an insect cell with a recombinant vector comprising: a promoter; a first polynucleotide operably linked to the promoter and encoded to produce a secreted protein; a candidate sequence operably linked to the first polynucleotide; and a second polynucleotide, operatively linked to the candidate sequence and encoded to produce a fluorescent Protein; and 201031757 • (b) Determine whether the candidate sequence has a translational level of self-cutting based on a pattern of light exhibited by the insect cell if the fluorescent 疋 is evenly distributed within the insect cell (including the nucleus) 'The candidate sequence is the similar _2a sequence; if the fluorescence exhibits a donut shape and is confined to the cell shuttle or secreted into the extracellular medium, then the candidate sequence is not the similar _2A sequence. In a preferred embodiment, the candidate sequence is isolated from the genus Perina nuda Picoma-like virus

PnV)基因且包含一序列編號:1之多核苷酸。以本 ❿發明方法鑑別出來的多核苷酸序列可編石馬產生包含 有一序列編號:2之胺基酸序列,其包含一位於甘 胺酸與脯胺酸之間的轉譯層級自我切割位置,且其 轉譯層級自我切割活性高達100%,表示該分泌性^ 白與該螢光蛋白是以大約1 : 1的比例產生。在另一 較佳實施方式中,該候選序列是分離自榕樹透翅毒 蛾類小病毒(Perina nuda Picoma-like virus,PnV)基 因且包含一序列編號:3之多核苷酸,其可編碼產 _ 生包含有一序列編號:4之胺基酸序列。在一實例 中’此螢光蛋白是一增強綠螢光蛋白(EGFP);且該 分泌性蛋白是一分泌性鹼性磷酸酶(SEAP)。 本發明另一目的在於提供一種用來鑑別具有一 轉譯層級自我切割活性之類似2 A序列的昆蟲系 統。該系統包含; 一昆蟲細胞,其被一重組載體轉染,該重組載體 包含以下序列: 一啟動子; 一第一多核苷酸,其係可操作地連結到該啟 動子並編碼產生一分泌性蛋白; 201031757 • 一候選序列,其係可操作地連結到該第一容 核苷酸;及 夕 一第二多核苷酸,其係可操作地連結到該候 選序列並編碼產生一螢光蛋白; 、 2中以在一螢光顯微鏡下所觀察到的該昆蟲細胞所 表現出來的一螢光模式來決定該候選序列是否是誃 類似-2A序列’如果螢光是均句地分佈在該昆蟲= 胞(包括細胞核)内,則該候選序列是該類似_2A序 列,如果螢光呈現一甜甜圈形狀且侷限在細胞核以 外的細胞質空間或是被分泌到細胞外介質中,則今 候選序列不是該類似-2A序列。 乂 本發明一或多實施方式的細節係如發明詳細說 ,與附圖中所示’在閱讀過以下實施方式說明與申 5青專利範圍後’將可更了解本發明特徵與優點。 需知所述本發明之一般性描述和實施方式明, 僅在闡述本發明理念,本發明範疇並不僅限於該等 敘述及實施例中。 【實施方式】 除非另做說明,否則所有本文中提及的名詞之含 意與微生物及重組DNA技術領域中具備通常知識 者的理解與認知一致。 以下將參照附圖來說明本發明用來鑑別具有— 轉譯層級自我切割活性之類似2A序列的系統和/或 方法。 ' 依據本發明一實施方式’提供一種用來在一昆 轰系統中鑑別具有一類似2 A序列的方法。此方法特 201031757 包ί:下步驟:(a)以一重組載體轉染-昆 ,細胞,该重組载體包含以下序列:一啟動子;一 第夕核苷駄其係可操作地連結到該啟動子並編 ,產生刀/必性蛋白;一候選序列,其係可操作地 連結到該第-多时酸;及—第二多核苷酸,其係 可操作地連結到該候選序列並編碼產生一螢光蛋 白,和(b)依據該昆蟲細胞所表現出來的一螢光模 式來決定該候選序収否具有—轉譯層級自我切割 活性’如果螢光是均勻地分佈在該昆蟲細胞内(包括 細胞核),則該候選序列為類似_2A序列;如果螢光 呈現一甜甜圈形狀且侷限在細胞核以外的空間或是 被分泌到細胞外介質中,則該候選序列不是該類似 -2A序列。 對本發明而s,具有轉譯層級自我切割活性之類 似2A的序列為病毒的DNA或cDNA,較佳是來自 微小病毒科famUy),包括但不限於 腸病毒、.鼻病#、肝病毒、心肌病毒、口瘡病毒 (aphth〇VlrUS)、副腸孤病毒(parech〇virus)、馬鼻病毒 ❹(erbovirus)、豬腸病毒(k〇buvirus)、捷申病毒 (teschovirus)、類小病毒(pic〇rna_like ^而)等。「轉 譯層級自我切割活性(translati〇nal self clevage activity)」一岡在此表示一序列藉由切割其c_端而 產生切割產物之自我蛋白裂解或切割的轉譯效果。 可依據與任何已知2A序列(例如,在心肌病毒及口 瘡病毒基因體中發現的2A序列,舉例來說,口蹄疫 病毒之2A序列)間的序列相似性、二級或三級結構 -類似性或是否存在任何保留序列區,來挑選出類似 2 A序列之潛在或候選序列。在一較佳實施方式中, 201031757 此候選序列是依據序列相似性而自榕樹透翅毒蛾類 小病毒基因中分離出來的,且包含一序列編號:i 或3之多核苷酸序列,此多核苷酸序列是與任一已 知 2A 序列至少 8〇%、81%、82%、83%、84%、、 86%、87%、88%、890/0、90%、91%、92%、93%、 94%、95%、96%、97%、98%、99%或 1〇〇%相同。 將依據上述方法所挑選出來的候選序列與其他 兩個報導基因一同轉殖到重組載體中。「報導基因 (reporter gene)」一詞在此代表一基因透過其本身獨 特的特性,例如在宿主細胞内的螢光表現模式或分 泌能力,而使本發明t的候選基因可以依據本發明 所界定的條件(將詳述於下)而被鑑別出來。在本發 明中’以報導基因的表現方式,例如,在宿主細胞 内,螢光表現模式或分泌能力,做為判定一候選序 列是否為欲求之類似2A序列的指標。在一較佳實施 =式中,以基因工程方式使重組載體依序包含以下 =:-啟動子;—第—報導基因,其係可操作式 、連結到該啟動子並編碼產生一分泌性蛋白;一候 選序列,其係可操作式地連結到該第一多核苷酸; 及第一報導基因,其係可操作地連結到該候選序 列並編碼產生一螢光蛋白。「啟動子(pr〇m〇ter)」一 词代表具有能夠啟動其序列下游所編碼序列之轉錄 作用的核酸序列。啟動子可以是誘發式的或是且細 一性的。可用在昆蟲細胞表現系統的啟動子為 夕角體(?〇1沖€(11^)、1?1〇、%39、41和162啟動子, 且較佳是多角體啟動子。「可操作式地連結(〇州物 =ed)」—詞代表在一重組載體中,一多胜狀編碼 彳〃轉錄及轉譯控制序列的連接方式係使得當適 201031757 當分子(如,轉譯活化蛋白)與控制序列結合後,可 ’ 表現該多胜肽。第一報導基因可編碼產生一分泌性 蛋白,例如一種分泌式的鹼性磷酸酶(SEAP)。第二 報導基因可編碼產生一螢光蛋白,包括但不限於, 綠螢光蛋白(green fluorescent protein,GFP)、增強綠 螢光蛋白(enhanced green fluorescent protein, EGFP)、藍螢光蛋白(blue fluorescent protein, BFP)、 增強黃螢光蛋白(enhanced yellow fluorescent protein, EYFP)、粉紅海葵螢光蛋白 ❹ fluorescent protein,amFP)、兔海蔡螢光蛋白 fluorescent protein,zFP)、圓盤海葵螢光 蛋白(Dzseosoma fluorescent protein,dsFP)、軟珊蝴 螢光蛋白(C7avw/arza fluorescent protein, cFP)、螢光 素酶(例如,螢火蟲螢光素酶)、水母螢光素酶 reniformis luciferase)和角毛藤螢光素酶 wwe//erz· luciferase)。在一實例中,第一報導基因編 碼產生SEAP ’且第二報導基因編碼產生EGFP。適 當的病毒載體可以來自桿狀病毒(baculoviruses),包 括但不限於,AcMNPV califomica nuclear polyhedrosis virus) ' PnMNPV (Perina nuda multinucleocapsid nuclear polyhedrosis vims) > BmNPV (Bombyx mori nuclear polyhedrosis virus) > LdMNPV {Lymantria i/wpar multinucleocapsid nuclear polyhedrosis virus) ^ OpMNPV {Orgyia pseudotsugata multicapsid nucleopolyhedrovirus)。 將依據本發明一較佳實例所製備出來的重組載 體用來轉染一昆蟲系統,例如秋行軍蟲 IPBL-sf2 1細胞株。但是,也可使用其他 的昆蟲表現系統。此領域中具備通常知識者將可了 201031757 _ 解,如果被併入至上述融合核酸(即,一 以下序列的核酸:第一報導基因;^依序包含 報導基因)的候選序列是一種類似=和第二 可分別表現出第一和第二報導美疋 彳’其將 即分泌性蛋白和螢光蛋白,且二八v蛋白質產物, 被傳送到細胞外介質,而螢先===性蛋白最後會 細胞内。相反的,如』繼續留在宿主 後選序列不是-種類似2/的入^;^ =核酸中的 二報導蛋白彼此連接在起將而第:報導蛋白與第 白。此融合蛋白最後會因為所連接 蛋 倚賴傳統費時、費力的蛋定序二^ ί 生測試等。在-較佳實施方式 單獨的蛋白質產1 二 ==分佈模式,代表=序= 二1列’因此產生並分泌-個大型的融 合蛋白’而非兩個單想沾疋 + 4* 獨的蛋白質;因此,螢光侷限 在、,.田胞2外的二間中或是被分泌 而呈現出甜甜圈形狀的分佈模式。胞卜,丨質中 在一較佳實施方洼 序列或是候選序列包大含中有’ m出來的類似/ α的 序列的多胜肽,該ΐ胜列編號··2之胺基酸 夕胜肽在甘胺酸與脯胺酸之間具 201031757 有一自我切割位置。在另一較佳實施方式中, 別出來的類似2A的序列或是候選序列包含有一 ^ 列編號:3的多核苷酸序列,可編碼產生一具 列編號.4之胺基酸序列的多胜肽。 此外,本發明的方法和/或系統也可平衡地或 分子式地製造出兩種蛋白質產物,亦即,兩報美 是以實質上相同的量被製造。在一較佳實ς 方式中,由第一報導基因所編碼產生的分泌性 的量與由第二報導基因所編碼產生The PnV) gene also comprises a polynucleotide of sequence number: 1. The polynucleotide sequence identified by the method of the present invention can be used to generate an amino acid sequence comprising a sequence number: 2, comprising a translational level self-cleaving position between glycine and valine acid, and Its translation level self-cleavage activity is as high as 100%, indicating that the secretory protein and the fluorescent protein are produced in a ratio of approximately 1:1. In another preferred embodiment, the candidate sequence is a Perina nuda Picoma-like virus (PnV) gene isolated and comprises a polynucleotide of SEQ ID NO: 3, which can be encoded. The sequence contains an amino acid sequence of sequence number: 4. In one example, the fluorescent protein is an enhanced green fluorescent protein (EGFP); and the secreted protein is a secreted alkaline phosphatase (SEAP). Another object of the present invention is to provide an insect system for identifying a similar 2 A sequence having a translational level of self-cleavage activity. The system comprises: an insect cell transfected with a recombinant vector comprising: a promoter; a first polynucleotide operably linked to the promoter and encoding to produce a secretion a protein; 201031757 • a candidate sequence operably linked to the first capacitive nucleotide; and a second polynucleotide operably linked to the candidate sequence and encoding to generate a fluorescent In the protein; 2, a fluorescent pattern exhibited by the insect cell observed under a fluorescence microscope determines whether the candidate sequence is a -2-like -2A sequence' if the fluorescence is uniformly distributed in the In the insect = cell (including the nucleus), the candidate sequence is the similar _2A sequence. If the fluorescence exhibits a donut shape and is confined to the cytoplasmic space outside the nucleus or is secreted into the extracellular medium, then the candidate The sequence is not this similar -2A sequence. The details of one or more embodiments of the present invention are set forth in the Detailed Description of the invention, and the description of the embodiments of the invention. It is to be understood that the invention is not intended to be limited [Embodiment] Unless otherwise stated, all the meanings of the terms mentioned herein are consistent with the understanding and understanding of those having ordinary knowledge in the field of microorganisms and recombinant DNA technology. Hereinafter, a system and/or method for identifying a similar 2A sequence having a translation-level self-cleaving activity will be described with reference to the accompanying drawings. An embodiment for identifying a sequence having a similar 2 A in a quenching system is provided in accordance with an embodiment of the present invention. The method comprises the following steps: (a) transfecting a cell with a recombinant vector comprising the following sequence: a promoter; a nucleoside nucleoside operably linked thereto The promoter is conjugated to produce a knife/reactive protein; a candidate sequence operably linked to the first-time acid; and a second polynucleotide operably linked to the candidate sequence and encoded Generating a fluorescent protein, and (b) determining, based on a fluorescent pattern exhibited by the insect cell, whether the candidate sequence has a trans-layered self-cleaving activity' if the fluorescence is uniformly distributed within the insect cell ( Including the nucleus, the candidate sequence is a similar _2A sequence; if the fluorescence exhibits a donut shape and is confined to a space outside the nucleus or secreted into the extracellular medium, the candidate sequence is not the similar -2A sequence. . For the present invention, a sequence similar to 2A having a translational level of self-cleavage activity is a DNA or cDNA of a virus, preferably from the miniviridae famUy), including but not limited to enterovirus, nasal disease #, hepatic virus, cardiomyopathy , aphth〇VlrUS, parech〇virus, erbovirus, prubivirus, teschovirus, picovirus (pic〇rna_like) ^And). "Translati 〇nal self clevage activity" herein means a sequence of translational effects of self-protein cleavage or cleavage of a cleavage product by cleavage of its c-terminus. Sequence similarity, secondary or tertiary structure-similarity between any known 2A sequence (eg, 2A sequence found in cardiovirus and aphthous virus genomes, for example, 2A sequence of foot-and-mouth disease virus) Or if there are any reserved sequence regions to pick out potential or candidate sequences similar to the 2 A sequence. In a preferred embodiment, the candidate sequence of 201031757 is isolated from the eucalyptus urophylla virus gene according to sequence similarity and comprises a polynucleotide sequence of sequence number: i or 3, the polynucleoside The acid sequence is at least 8%, 81%, 82%, 83%, 84%, 86%, 87%, 88%, 890/0, 90%, 91%, 92%, and any known 2A sequence, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 1% are the same. The candidate sequences selected according to the above methods were co-transferred into the recombinant vector together with the other two reporter genes. The term "reporter gene" is used herein to mean a gene that has its own unique characteristics, such as a fluorescent expression pattern or secretion capacity in a host cell, such that the candidate gene of the invention can be defined in accordance with the invention. The conditions (which will be detailed below) are identified. In the present invention, the expression pattern of the reporter gene, for example, in the host cell, the fluorescence expression pattern or the secretion ability is used as an indicator for determining whether a candidate sequence is a similar 2A sequence as desired. In a preferred embodiment, the recombinant vector is genetically engineered to sequentially comprise the following =:-promoter; - a reporter gene operably linked to the promoter and encoding a secreted protein a candidate sequence operably linked to the first polynucleotide; and a first reporter gene operably linked to the candidate sequence and encoding to produce a fluorescent protein. The term "promoter" refers to a nucleic acid sequence having the ability to initiate transcription of a sequence encoded downstream of its sequence. Promoters can be inducible or subtle. The promoters that can be used in the insect cell expression system are the horn horn (?1 冲1 (11^), 1-1 〇, %39, 41 and 162 promoters, and preferably the polyhedrin promoter." Linking (〇州物=ed)--the word represents a linkage in a recombinant vector, encoding a transcriptional and translational control sequence, such that when the molecule (eg, translationally activated protein) The control sequence can be combined to express the multi-peptide. The first reporter gene can encode a secreted protein, such as a secreted alkaline phosphatase (SEAP). The second reporter gene can encode a fluorescent protein. Including, but not limited to, green fluorescent protein (GFP), enhanced green fluorescent protein (EGFP), blue fluorescent protein (BFP), enhanced yellow fluorescent protein (enhanced yellow fluorescent protein) Protein, EYFP), pink anemone fluorescent protein, amFP), rabbit fluorescein fluorescent protein, zFP), disc anemone fluorescent protein (Dzseosoma fluoresce Nt protein, dsFP), C7avw/arza fluorescent protein (cFP), luciferase (eg, firefly luciferase), remiformis luciferase, and hornbeam fluorescein Prime enzyme wwe / / erz · luciferase). In one example, the first reporter gene encodes a SEAP' and the second reporter gene encodes an EGFP. Suitable viral vectors may be derived from baculoviruses including, but not limited to, AcMNPV califomica nuclear polyhedrosis virus) 'PnMNPV (Perina nuda multinucleocapsid nuclear polyhedrosis vims) > BmNPV (Bombyx mori nuclear polyhedrosis virus) > LdMNPV {Lymantria i /wpar multinucleocapsid nuclear polyhedrosis virus) ^ OpMNPV {Orgyia pseudotsugata multicapsid nucleopolyhedrovirus). A recombinant vector prepared according to a preferred embodiment of the present invention is used to transfect an insect system, such as the autumn army worm IPBL-sf2 1 cell line. However, other insect expression systems can also be used. Those with ordinary knowledge in this field will be able to solve the 201031757 _ solution, if the candidate sequence is incorporated into the above fusion nucleic acid (ie, a nucleic acid of one sequence: the first reporter gene; the sequence contains the reporter gene) is a similar = And the second can exhibit the first and second reports respectively, which will be secreted proteins and fluorescent proteins, and the VIIIv protein product is delivered to the extracellular medium, and the serotonin === protein Finally, it will be inside the cell. Conversely, such as "continue to remain in the host, the selected sequence is not - a similar 2 / into ^ ^; ^ = two reporter proteins in the nucleic acid are linked to each other and the first: reporter protein and white. This fusion protein will eventually rely on the traditional time-consuming and laborious egg sequencing test for the connected eggs. In the preferred embodiment, the protein alone produces a two == distribution pattern, representing = sequence = two columns - thus producing and secreting - a large fusion protein' rather than two single-sense + 4* unique proteins Therefore, the fluorescence is limited to the distribution pattern of the donut shape in the two compartments outside the field cell 2. In the enamel, in the preferred embodiment of the enamel or in the candidate sequence, there is a multi-peptide of the similar/α-sequence of the 'm', and the amino acid of the 编号? The peptide has a self-cutting position between 2010 and 3,057,757 between glycine and valine. In another preferred embodiment, the alternative 2A-like sequence or candidate sequence comprises a polynucleotide sequence of 3:3, which encodes a multi-win of the amino acid sequence of column number 4. Peptide. Moreover, the methods and/or systems of the present invention can also produce two protein products in a balanced or molecular manner, i.e., two reports are manufactured in substantially the same amount. In a preferred embodiment, the amount of secretion produced by the first reporter gene is encoded by the second reporter gene.

❹ 的比例約為1 : 1。 1尤蛋白的里 右二月另一實施方式’提供一種用來鑑別具 j = l級自我切割活性之類似2八序列的系統。此The ratio of ❹ is about 1:1. Another embodiment of the 1st protein in the right second month provides a system for identifying similar 28-sequences with self-cleavage activity of j = l level. this

If二一昆蟲細胞,其被一重組載體轉染,該 重組載體包含下列序列:一啟動子;一第一多核苷 酸,其係可操作地連結到該啟動子並編碼產生」分 ;了候選序列,其係可操作地連結到該第 夕人酸,及一第二多核苷酸,其係可操作地連 結到該候選序列並編碼產生一螢光蛋白;1中以該 昆f細胞所表現出來的一螢光模式來決定該候選序 列,,是該類似-2Α序歹,J,如果螢光是均勻地分佈 在該昆蟲細胞内(包括細胞核),則該候選序列是該 序列;如果螢光呈現一甜甜圈形狀且褐限 、’、田^外或疋被分泌到細胞外介質中,則該候選 序列不是該類似-2Α序列。 明w知技藝人士有恰當的工具來使用本發 、發明所揭示的報導基因核酸與昆蟲細胞做 # ΐ1套組内提供病毒載體,用來建構出所需重 、、且、酵素試劑,用來擴增病毒數目的細胞,用 12 201031757 來轉染或轉化標的細胞的試劑,以及用來說明本發 • 明套組使用方法的解說手冊、錄音帶、CD、VCD或 DVD 等。 以下將藉由所揭示之非限制性的實施例闡述本 發明方法及内容。在閱讀過這些實例後,習知技藝 人士將能輕易推知本發明實施例更進一步的變化。 實施例1 建構表現載體If a two-in-one insect cell, which is transfected with a recombinant vector comprising the following sequence: a promoter; a first polynucleotide operably linked to the promoter and encoded to produce a "point"; a candidate sequence operably linked to the human acid, and a second polynucleotide operably linked to the candidate sequence and encoding to produce a fluorescent protein; A fluorescent pattern is expressed to determine the candidate sequence, which is a similar -2 sequence, J, if the fluorescence is evenly distributed within the insect cell (including the nucleus), then the candidate sequence is the sequence; If the fluorescence exhibits a donut shape and the brown limit, ', or the sputum is secreted into the extracellular medium, the candidate sequence is not the similar -2 Α sequence. The skilled person knows that the skilled person has the right tools to use the reporter gene and the insect cell disclosed in the invention to provide the virus vector in the set of ΐ1, to construct the required weight, and enzyme reagent for use. Amplify the number of cells in the virus, use 12 201031757 to transfect or transform the reagents of the target cells, and explain the instructions, tapes, CDs, VCDs, or DVDs used to explain the use of the set. The methods and content of the present invention are set forth below by way of the non-limiting embodiments disclosed. After reading these examples, those skilled in the art will readily be able to deduce further variations of the embodiments of the invention. Example 1 Constructing a performance carrier

1.1 pBac-S-Rhir-E φ 依據與陳等人用來建構pBac-Drhir-E載體 (S/oc/?e/77· anc/B/o〆^/Res. Co/T7/m/· 2005 335; 616-623)類似 的方法來建構pBac-S-Rhir-E載體,但其中以SEAP 基因來取代DsRed基因。因此,pBac-S-Rhir-E載體 依序包含SEAP基因、稻麥财病毒(R/?opa/os/p/7i/mpad/' virus,RhPV)之IRES序列及EGFP報導基因。1.1 pBac-S-Rhir-E φ was used to construct pBac-Drhir-E vector according to Chen et al. (S/oc/?e/77· anc/B/o〆^/Res. Co/T7/m/· 2005 335; 616-623) A similar approach was used to construct the pBac-S-Rhir-E vector, but in which the DsRed gene was replaced by the SEAP gene. Therefore, the pBac-S-Rhir-E vector sequentially contains the SEAPS gene, the IRES sequence of rice/rice virus (R/?opa/os/p/7i/mpad/' virus, RhPV) and the EGFP reporter gene.

1.2 pBac-SEFP 在pBac_Drhir-E載體中,將SEAP基因與EGFP φ 基因以譯讀框架内黏合方式(in-framed fused)接合 在一起(Chen et al.,Biochem. andBiophy.lRes. Commu. 2005 335; 616-623)。簡言之,先將來自pGS-HCV質體(Lee ei a/., S/oiec/7/?o· and β/oensf. 2005 90:656-672)中的 SEAP 基因片段,以聚合酶鏈反應經由正向引子, 5,-ATATAAGATCTCCACCATGCTGCTGCTGTGCTGCTGCTG GG-3’(序列編號:5,劃底線處為川位置)和反向引 子,5,-AATTCAGATCTGGTGTCTGCTCGAAGCGGCCGGC-3,1.2 pBac-SEFP In the pBac_Drhir-E vector, the SEAP gene and the EGFP φ gene were ligated in-framed fused (Chen et al., Biochem. and Biophy.lRes. Commu. 2005 335 ; 616-623). Briefly, the SEAP gene fragment from pGS-HCV plastid (Lee ei a/., S/oiec/7/?o· and β/oensf. 2005 90:656-672) was first polymerase chain The reaction is via a forward primer, 5,-ATATAAGATCTCCACCATGCTGCTGCTGTGCTGCTGCTG GG-3' (sequence number: 5, the bottom line is the Sichuan position) and the reverse primer, 5,-AATTCAGATCTGGTGTCTGCTCGAAGCGGCCGGC-3,

(序列編號:6 ’劃底線處為8g/N位置),加以擴增。 在反向引子中加入兩個GG核苷,使得可在SEAP 13 201031757 基因的3’_端與EGFP基因的5,-端之間,進行譯讀 框架内黏合。PCR後,將1 6 kb,切割過的§eAP 基因片段轉殖入經丨切割過的pBac-Drhir-E質體中, 並將所產生的質體命名為pBac-Drhir-SEFP,此質體 依序包含DsRed報導基因、RhPV IRES序列、和 SEAP及EGFP的融合基因。 接著,再用8a/?7HI和Sa/丨限制酶來切割pBac-S-Rhir-E 質體’以移除其中的SEAP-Rhir-EGFP片段。同樣,用丨 和Sa/I限制酶來切割pBac_DRhir-SEAP質體,以移除其中的 • SEAP_EGFP融合片段。接著,將SEAP-EGFP融合片段轉殖入 pBac-S-Rhir-E質體中的和Sa/丨限制酶切割位置處,將 所得的質體命名為pBac-SEFP。(Sequence number: 6 ‘ bottom line is 8 g/N position), and amplified. Two GG nucleosides were added to the reverse primer so that the 3'-end of the SEAP 13 201031757 gene and the 5'-end of the EGFP gene were ligated in the translational framework. After PCR, the 16 kb, cleaved §eAP gene fragment was transferred into the sputum-cut pBac-Drhir-E plastid, and the resulting plastid was named pBac-Drhir-SEFP. The DsRed reporter gene, the RhPV IRES sequence, and the fusion gene of SEAP and EGFP are sequentially included. Next, the pBac-S-Rhir-E plasmid was cleaved with 8a/?7HI and Sa/丨 restriction enzyme to remove the SEAP-Rhir-EGFP fragment therein. Similarly, the pBac_DRhir-SEAP plasmid was cleaved with 丨 and Sa/I restriction enzymes to remove the • SEAP_EGFP fusion fragment. Next, the SEAP-EGFP fusion fragment was transfected into the pBac-S-Rhir-E plasmid and the Sa/丨 restriction enzyme cleavage site, and the resulting plasmid was named pBac-SEFP.

1.3 pBac-S-PV2Al-E 以聚合酶鏈反應 (PCR) 將取自 pBac_DsRed-PnV-SEAP-RhPV-EGFP 質體之SEAP-PV2A1 基因 片 段 經 由正_ 向引子 , S'-AATGGATCCGCTAGCCCACCATGCTGCTGCTGCTGCTG-參 3’(序列編號:7,劃底線處為BamHI位置)和反向引子, S^AATAGMCTAAGGGTCCGGGGATTTGACTCAACATCTCC ATCCACAGTCAAATCCGGAACCCACCCCTGGGCTGTCTGC TCGAAGCGGCC-3,(序列編號:8,劃底線處為川位 置)力σ以擴增。 將擴增後的SEAP-PnV2Al序列與PCR2.1 (IUSA) 用在TA轉殖,將所得質體命名為PCR2.1/SEAP-PnV2Al。以 SamAVI 和 Bgf川來切割此 PCR2.1/SEAP-PnV2Al質體,並移除其中的SEAP-PnV2Al序列。 接著將所切割出來的SEAP-PnV2Al序列連接到 14 201031757 pBac-S-Rhir-E質體中的BamAY丨和β〇ι川服制酶切割位置處, 將所得的質體命名為pBac-S-PnV2Al-E。 1.4 建構重組載體 將秋行軍蟲(》S. IPBL-sf21細胞株培 養在内含8%熱失活胎牛血清的TNM-FH培養基質 中,直到已長滿單層細胞為止(約2xl05細胞/培養 孔)。利用 Ιμΐ 的 CellfectinTM 轉染試劑(Invitrogen Corp·, Carlsbad, California)將 0.8pg 的實施例 1.1 (pBac-S-Rhir-E) 、 1.2 (pBac-SEFP) 、 1.3 ❿ (pBac-S-PnV2Al-E)之質體與線性化Bac-N-Blue桿 狀病毒DNA (0·25μδ)轉染到前述單層、長滿的sf21 細胞中。將轉染後的細胞培養在不含胎牛血清的 TNM-FH培養基質中12小時,接著再繼續培養在内 含8%熱失活胎牛血清的TNM-FH培養基質中。 如果Bac-N-Blue桿狀病毒DNA與3種質體,即 實施例 1·1 (pBac-S-Rhir-E)、1.2 (pBac-SEFP)、1.3 (pBac-S-PnV2Al-E)之質體基因,發生同源重組,會 產生新的重組桿菌表現載體,這些新形成的重組載 • 體可借助從共同表現的EGFP蛋白所發出的綠螢 光,而以習知的終點稀釋法加以篩選出來。將所筛 選出來的重組載體分別命名為vAc-S-Rhir-E、vAc-SEFP 及 vAc-S-PnV2AI-E 〇 第1圖示出上述3種重組載體的結構示意圖,包 括(A) vAc-S-Rhir-E; (B) vAc-SEFP及(C) vAc-S-PnV2AI-E。 用於本發明的啟動子為多面體啟動子(以下簡稱為 Pph)。另外’使用重組vAc-S-Rhir-E和vAc-SEFP病毒 - 表現載體做為vAc-S-PnV2AI-E載體的控制對照組。 15 201031757 實施例2 鑑別類似2A的序列 2.1 依棱螢光模式逸扞籂撰 如果實施例1.4之重組載體中所篩選出來的類似 PnV2A序列並不具有核醣體跳躍活性的話,則SEAP 基因、類似PnV2A序列和EGFP基因會表現在同一 轉譯物中,即融合蛋白。因此,會表現出依序包含 有SEAP、類似PnV2A胜肽及EGFP的融合蛋白, 且此融合蛋白因為含有SEAP的緣故,最終會被分 泌到細胞外,使得從EGFP所發出的綠螢光會侷限 φ 在細胞核外並最終分泌至細胞外。相反的,如果所 篩選出來的類似PnV2A序列含有核醣體跳躍活性的 話,則轉譯物會從類似PnV2A序列處被切斷。因此, SEAP和EGFP會各自以單獨的蛋白質形式表現,且 EGFP會留在細胞中,使得從EGFP所發出的綠螢光 會均勻分佈於細胞中(包含細胞核),且不會分泌到 細胞外。 將分別轉染有 vAc-S-Rhir-E、vAc-SEFP及 vAc-S-PnV2AI-E之載體的Sf21細胞(2xl05細胞/培養 Φ 孔,共24個培養孔)以300毫升的裂解試劑(1〇〇 mM potassium phosphate (pH 7.8), 1 mM EDTA, 10% Triton X-100 和7 mM β-氫硫乙醇)裂解10分鐘。接著在128,000 rpm速度下離 心30分鐘,取出少量的上清液進行螢光測量。以Cary Eclipse螢 光光譜儀(Varian)在488 nm的激發光波長及507 nm的發散光波長 下測量EGFP的螢光光譜。 第 2 圖為分別以(A) vAc-S-Rhir-E、(B) vAc-S-PnV2AI-E 及(C) vAc-SEFP之載體轉染Sf21細胞後,Sf21細胞 所表現出來的螢光分佈模式的照片。在第2A圖中, 可確認以vAc-S-Rhir-E轉染的Sf21細胞中,SEAP是 16 201031757 利用CAP-依賴型轉錄作用而表現,EGFP則是利用 _ RhPV IRES序列來表現’因此從EGFP發出的綠螢 光侷限在細胞内且分佈均勻。在第2B圖中,在轉染 有vAc-S-PnV2AI-E的Sf21細胞中,其綠螢光得分佈模 式與上述轉染有vAc-S-Rhir-E的Sf21細胞類似,代表 類似PnV2A的序列能夠自我切割,因此共同表現的EGFP同樣 也分佈在細胞核内。 相反的,在第2C圖中,以vAc-SEFP載體轉染的 Sf21細胞,其螢光分佈模式呈現甜甜圈形狀,代表 ❹ Sf21細胞合成一融合蛋白(包含SEAP和EGFP)後, 又將其分泌到細胞外,因此螢光才會侷限在細胞核 外並分泌到基質中。換言之,如果桿狀病毒載體中 所篩選出來的類似2A的序列表現出與以vAc-SEFP載 體轉染後相同的螢光分佈模式,代表所篩選出來的 序列並非欲求的類似2A的序列,因此無法自我切割 或是誘發核醣體跳躍活性。 2.2 依據西方墨點分析進行篩選 • 進一步以西方墨點分析來確認所篩選出來的類 似PnV2A序列之轉譯層級自我切割活性。簡言之, 分別以實施例1.4中的重組載體,包括vAc-S-Rhir-E、 vAc-S-PnV2AI-E 及 vAc_SEFP,來轉染 Sf21 細胞,之後, 再將細胞裂解,並以SDS-PAGE來分離裂解細胞内 的蛋白質產物,再將所分離出來的蛋白質產物轉移 到聚氟乙烯膜(PVDF,millipore)上。在室溫下’將 PVDF膜以内含5%牛血清白蛋白(BSA,Sigma)之 Tris 緩衝液(100 mM Tris, pH7.4; 100mM NaC丨和 0.1% Tween 20)封鎖約1小時。 17 201031757 封鎖反應後,在4°C下,讓PVDF膜與抗-EGFP 抗體(1:2000, BD Biosciences ClonTech, Palo Alto, CA)反應 隔夜。之後,在室溫下以Tris緩衝液清洗PVDF膜 3次,每次5分鐘,以徹底移除未結合的抗-EGFP 抗體。之後,在室溫下,將此PVDF膜與和山葵過 氧化酶形成共輛的二級抗體(1:2500, Jackson)—起反應 約1小時。之後,在室溫下以Tris緩衝液清洗PVDF 膜3次,每次5分鐘,以徹底移除未結合的二級抗 體。結果示於第3圖中。 φ 如果候選的PnV2A序列可誘發核醣體跳躍, EGFP和SEAP將可被分別表現成兩個獨立的蛋白 質,因此可偵測到分子量大約27kDa的EGFP蛋白。 相反的,如果候選的PnV2A序列無法自我切割,則 會偵測到分子量大約l〇〇kDa之由EGFP和SEAP共 同組成的融合蛋白。 第3圖示出以包括vAc-S-PnV2AI-E、vAc-SEFP和 vAc-S-Rhir-E之重組載體來轉染Sf21細胞後,細胞 (分別為圖上之第1、3及5道)與細胞外基質(分別為 ❹ 圖上之第2、4及6道)中的EGFP含量。很明顯的, 在以vAc-S-PnV2AI-E轉染的細胞核内可偵測到分子量大約 27kDa的EGFP蛋白,表示vAc-S-PnV2AI-E中的候選序列 是欲求的PnV2A序列,可進行自我切割(比較第3圖 中第1道與第2道的結果)。以vAc-S-Rhir-E轉染的細胞 也表現出與以以vAc-S-PnV2AI-E轉染的細胞同樣的結果(比較 第3圖中第5道與第6道的結果)。至於圖中第4道, 則出現分子量大約1 〇〇kDa的融合蛋白’代表EGFP 與SEAP彼此融合成一大的融合蛋白。 此外,第3圖中第1道與第2道的結果也顯示, 18 2010317571.3 pBac-S-PV2Al-E The SEAP-PV2A1 gene fragment from pBac_DsRed-PnV-SEAP-RhPV-EGFP plastid was passed through the positive-direction primer by polymerase chain reaction (PCR), S'-AATGGATCCGCTAGCCCACCATGCTGCTGCTGCTGCTG-parameter 3' (SEQ ID NO: 7, bottom line is BamHI position) and reverse primer, S^AATAGMCTAAGGGTCCGGGGATTTGACTCAACATCTCC ATCCACAGTCAAATCCGGAACCCACCCCTGGGCTGTCTGC TCGAAGCGGCC-3, (sequence number: 8, bottom line is the Sichuan position) force σ to amplify. The amplified SEAP-PnV2Al sequence and PCR2.1 (IUSA) were used for TA transfer, and the resulting plasmid was named PCR2.1/SEAP-PnV2Al. The PCR2.1/SEAP-PnV2Al plasmid was cleaved with SamAVI and Bgf, and the SEAP-PnV2Al sequence was removed. Then, the cut SEAP-PnV2Al sequence was ligated to the BamAY丨 and β〇ιchuan enzyme-cutting positions in the 14 201031757 pBac-S-Rhir-E plastid, and the obtained plastid was named pBac-S- PnV2Al-E. 1.4 Construction of the recombinant vector The S. IPBL-sf21 cell line was cultured in TNM-FH medium containing 8% heat-inactivated fetal bovine serum until it had grown to a single layer of cells (about 2×10 5 cells/ Culture wells. 0.8 pg of Example 1.1 (pBac-S-Rhir-E), 1.2 (pBac-SEFP), 1.3 ❿ (pBac-S) using Ιμΐ CellfectinTM Transfection Reagent (Invitrogen Corp., Carlsbad, California) The plastid of -PnV2Al-E) and the linearized Bac-N-Blue baculovirus DNA (0·25μδ) were transfected into the aforementioned monolayer, overgrown sf21 cells. The transfected cells were cultured in a non-fetal The bovine serum was cultured in TNM-FH medium for 12 hours, and then continued to be cultured in TNM-FH medium containing 8% heat-inactivated fetal bovine serum. If Bac-N-Blue baculovirus DNA and 3 plastids , ie, the plastid genes of Example 1·1 (pBac-S-Rhir-E), 1.2 (pBac-SEFP), 1.3 (pBac-S-PnV2Al-E), homologous recombination, will produce new recombinant bacilli Expression vectors, these newly formed recombinant vectors can be screened by conventional endpoint dilution methods by means of green fluorescence emitted from the co-expressed EGFP protein. The selected recombinant vectors were named vAc-S-Rhir-E, vAc-SEFP and vAc-S-PnV2AI-E, respectively. Figure 1 shows the structure of the above three recombinant vectors, including (A) vAc-S-Rhir-E; (B) vAc-SEFP and (C) vAc-S-PnV2AI-E. The promoter used in the present invention is a polyhedrin promoter (hereinafter referred to as Pph). In addition, 'recombinant vAc- is used. S-Rhir-E and vAc-SEFP virus-expression vectors were used as control controls for the vAc-S-PnV2AI-E vector. 15 201031757 Example 2 Identification of sequences similar to 2A 2.1 Depending on the fluorescing mode If the similar PnV2A sequence screened in the recombinant vector of Example 1.4 does not have ribosome skipping activity, the SEAP gene, PnV2A-like sequence and EGFP gene will be expressed in the same translation, ie, the fusion protein. The sequence contains SEAP, a fusion protein similar to PnV2A peptide and EGFP, and this fusion protein will eventually be secreted outside the cell because of the SEAP, so that the green fluorescence emitted from EGFP will be limited to φ outside the nucleus and eventually Secreted to the outside of the cell. Conversely, if it is screened out Similar activity PnV2A hopping sequence contains ribosomes, then translation thereof is cut off from the sequences similar PnV2A. Therefore, SEAP and EGFP will each be expressed in a separate protein form, and EGFP will remain in the cells, so that the green fluorescence emitted from EGFP will be evenly distributed in the cells (including the nucleus) and will not be secreted outside the cell. Sf21 cells (2xl05 cells/culture Φ wells, 24 culture wells) transfected with vectors of vAc-S-Rhir-E, vAc-SEFP and vAc-S-PnV2AI-E, respectively, were treated with 300 ml of lysis reagent ( 1 mM potassium phosphate (pH 7.8), 1 mM EDTA, 10% Triton X-100 and 7 mM β-hydrogenthioethanol) were lysed for 10 minutes. Then, it was centrifuged at 128,000 rpm for 30 minutes, and a small amount of the supernatant was taken out for fluorescence measurement. The fluorescence spectrum of EGFP was measured by a Cary Eclipse fluorescence spectrometer (Varian) at an excitation light wavelength of 488 nm and a divergent light wavelength of 507 nm. Figure 2 shows the fluorescence of Sf21 cells after transfection of Sf21 cells with (A) vAc-S-Rhir-E, (B) vAc-S-PnV2AI-E and (C) vAc-SEFP vectors, respectively. A photo of the distribution pattern. In Figure 2A, it was confirmed that in Sf21 cells transfected with vAc-S-Rhir-E, SEAP was 16 201031757 expressed by CAP-dependent transcription, and EGFP was expressed by _ RhPV IRES sequence. The green fluorescence emitted by EGFP is confined within the cell and evenly distributed. In Figure 2B, in the Sf21 cells transfected with vAc-S-PnV2AI-E, the green fluorescence distribution pattern was similar to that of the above-described Sf21 cells transfected with vAc-S-Rhir-E, representing PnV2A-like The sequence is self-cleavable, so the co-expressed EGFP is also distributed in the nucleus. In contrast, in Figure 2C, the Sf21 cells transfected with the vAc-SEFP vector exhibited a donut shape in the form of a fluorescence distribution pattern, representing that Sf21 cells synthesized a fusion protein (including SEAP and EGFP) and then Secreted outside the cell, so the fluorescence is confined to the nucleus and secreted into the matrix. In other words, if the 2A-like sequence screened in the baculovirus vector exhibits the same fluorescence distribution pattern as that after transfection with the vAc-SEFP vector, it means that the selected sequence is not a similar 2A-like sequence, and therefore cannot be Self-cutting or inducing ribosome skipping activity. 2.2 Screening based on Western blot analysis • Western blot analysis was used to confirm the translational level of self-cleavage activity of the selected PnV2A sequence. Briefly, Sf21 cells were transfected with the recombinant vectors of Example 1.4, including vAc-S-Rhir-E, vAc-S-PnV2AI-E and vAc_SEFP, respectively, after which the cells were lysed and SDS- PAGE is used to separate the protein product in the lysed cells, and the separated protein product is transferred to a polyvinyl fluoride membrane (PVDF, millipore). The PVDF membrane was blocked with Tris buffer (100 mM Tris, pH 7.4; 100 mM NaC® and 0.1% Tween 20) containing 5% bovine serum albumin (BSA, Sigma) for about 1 hour at room temperature. 17 201031757 After blocking the reaction, the PVDF membrane was allowed to react with anti-EGFP antibody (1:2000, BD Biosciences ClonTech, Palo Alto, CA) overnight at 4 °C. Thereafter, the PVDF membrane was washed 3 times with Tris buffer at room temperature for 5 minutes each time to completely remove unbound anti-EGFP antibody. Thereafter, the PVDF membrane was reacted with a horseradish peroxidase to form a secondary secondary antibody (1:2500, Jackson) at room temperature for about one hour. Thereafter, the PVDF membrane was washed 3 times with Tris buffer at room temperature for 5 minutes each time to completely remove the unbound secondary antibody. The results are shown in Figure 3. φ If the candidate PnV2A sequence can induce ribosome hopping, EGFP and SEAP will be expressed as two separate proteins, thus detecting an EGFP protein with a molecular weight of approximately 27 kDa. Conversely, if the candidate PnV2A sequence is unable to self-cleave, a fusion protein consisting of EGFP and SEAP with a molecular weight of approximately l〇〇kDa is detected. Figure 3 shows cells transfected with Sf21 cells with recombinant vectors including vAc-S-PnV2AI-E, vAc-SEFP and vAc-S-Rhir-E (Figures 1, 3 and 5, respectively) And the EGFP content in the extracellular matrix (differents 2, 4 and 6 on the map, respectively). Obviously, an EGFP protein with a molecular weight of about 27 kDa can be detected in the nucleus transfected with vAc-S-PnV2AI-E, indicating that the candidate sequence in vAc-S-PnV2AI-E is the desired PnV2A sequence, which can be self-existing. Cutting (compare the results of the first and second tracks in Figure 3). The cells transfected with vAc-S-Rhir-E also showed the same results as those transfected with vAc-S-PnV2AI-E (compare the results of lanes 5 and 6 in Fig. 3). As for the fourth lane in the figure, a fusion protein having a molecular weight of about 1 〇〇 kDa represents that EGFP and SEAP are fused to each other to form a large fusion protein. In addition, the results of the first and second tracks in Figure 3 also show that 18 201031757

PnV2A序列的自我切割活性可高達100%,因為幾乎 ' 沒有偵測不到融合蛋白的存在。 2.3 依攄分泌性鹼性磷酸醢(SEAP)活性來進行篩 進一步以西方墨點分析來確認所篩選出來的類 似PnV2A序列之轉譯層級自我切割活性。The self-cleavage activity of the PnV2A sequence can be as high as 100% because almost no fusion protein is detected. 2.3 Screening based on secreted alkaline strontium phosphate (SEAP) activity Western blot analysis was used to confirm the translational level of self-cleavage activity of the similar PnV2A sequences screened.

分別收集以 vAc-S-PnV2AI-E、vAc-SEFP 或 vAc-S-Rhi「-E 之重組載體轉染的Sf21細胞的培養基’之後在在 φ 12,000rpm速度下離心10秒,並保存在-20°C下直到要測量SEAP 活性時為止。以BD Great EscApe SEAP檢驗套組 (Cat. No. K2041-1,購自 Clontech)來測量 SEAP 活 性。以化學冷光計數器(Mithras LB 940)來债測代表 SEAP活性的化學冷光強度。 第4圖顯示分別以 vAc-S-Rhir-E、vAc-SEFP或 vAc-S-PnV2AI-E之重組載體轉染Sf21細胞後,細胞所 表現出來的 SEAP活性的強度。很明顯的,以 vAc-S-PnV2AI-E轉染的Sf21細胞中的SEAP活性遠高 • 於以vAc-SEFP轉染的Sf21細胞中的SEAP活性,大 約為500倍。因此,在vAc-S-PnV2AI-E載體中所篩選 出來的候選序列可成功地誘發核醣體跳躍,避免掉 融合蛋白中因蛋白折疊所致的干擾缺陷,且不影響 標的蛋白的活性。有趣的是’以vAc_S-PnV2AI-E轉染 的Sf21細胞中的SEAP活性同樣遠高於以 vAc-S-Rhir-E轉染的Sf21細胞中的SEAP活性,而在 vAc-S-Rhir-E轉染的細胞中,SEAP和EGFP同樣也都是以單獨 蛋白質形式表現。以vAc-S-PnV2AI-E轉染的Sf21細胞中 的SEAP活性約比以vAc-S-Rhir-E轉染的Sf21細胞中 201031757 的SEAP活性高出1 00倍。發明人認為此可能是因 ' 為類似PnV2A的序列之mRNA較RhPV IRES序列 之mRNA來得穩定之故。 2.4 定量綠螢光 可利用冷光套組(Piece)來定量在PVDF膜上的 EGFP蛋白的量。結果示於第5圖,其示出分別以 vAc-S-Rhir-E、vAc-SEFP 或 vAc-S,PnV2AI,E 之重組載體轉 染Sf21細胞後,Sf2 1細胞中的螢光模式。同樣的, p 以vAc-S-PnV2AI-E轉染的Sf21細胞中的EGFP螢光強 度遠高於分別以vAc-SEFP或vAc-S-Rhir-E轉染的Sf21 細胞中的EGFP螢光強度。因此,很清楚的,與EGFP 融合之類似PnV2A序列的自我切割活性不會影響 EGFP的螢光強度。 實施例3 依據實施例2方法所鑑別出來的另一類 似2A的序列 依據實施例2所揭示的方法鑑別並轉殖出另一 ❹ 類似2A的序列。轉染有此序列的昆蟲宿主細胞在螢 光顯微鏡下同樣表現出甜甜圈形狀的螢光分佈模 式,因此可確認所鑑別出來的序列為類似2A的序 列。此序列經過定序後,發現其包含序列編號:3 的多核苷酸序列,並可編碼產生包含有序列編號:4 之胺基酸序列的多胜肽。 產業利用性 本發明利用在昆蟲宿主細胞中共同表現出兩種 報導蛋白質-分泌性蛋白與螢光蛋白後,宿主細胞所 20 201031757 產生的螢光分佈模式來篩選出欲求的類似2A的序 列。首先,先以依據本發明方法構築而成之包含 候,序列以及兩種報導基因的重組載體,來轉&昆 蟲值主細胞,然後利用在螢光顯微鏡下觀察轉化之 昆蟲宿主細胞内的螢光分佈模式,而決定出所挑 的候選序列是不是所要的類似2A的序列。甜甜圈形 狀的螢光分佈模式代表所挑選的候選序列並不是所 要的類似2A的序列,相反的,均勻分布在細胞内的 螢光模式則代表所挑選的候選序列就是所要的類似 ❿ 2A的序列。因此,本發明提供一種簡單快速且 使用的篩選方法和/或系統,其可用來鑑別出具有轉 譯層級自我切割活性的類似2a的序列。 雖然本發明已參照圖示及實施例詳細說明如 亡,但習知技藝人士應能了解在不悖離本發明精神 範疇下,可對所揭示的發明内容及實施例作各種變 化及改良,該等變化及改良應仍視為以下附隨之本 φ 發明申請專利範圍所涵蓋的範圍。 【圖式簡單說明】 第 1 圖示出(A)VAC-S-Rhir-E,(B) VAOSEFP 及(C) vAc-^PnV2AI-E之重組載體的結構示意圖; 第2圖不出以第!圖中所示3種重組載體轉染 Sf21細胞天後,細胞所表現的螢光模式照片; 第3圖不出以第丨圖之重組載體來轉染細 以西方墨點分析所測得的Sf2l細胞核中 EGFP含量; 21 201031757 第4圖的柱狀圖說明以第1圖之重組載體來轉染 ' Sf21細胞後,所測得的SEAP活性;及 第5圖的柱狀圖說明以第1圖之重組載體來轉染 Sf21細胞後,表現出來的EGFP的定量結果。 【主要元件符號說明】 無元件符號The medium of Sf21 cells transfected with the recombinant vector of vAc-S-PnV2AI-E, vAc-SEFP or vAc-S-Rhi "-E" was separately collected and then centrifuged at φ 12,000 rpm for 10 seconds and stored in - The SEAP activity was measured at 20 ° C until the SEAP activity was measured. The SEAP activity was measured with the BD Great EscApe SEAP test kit (Cat. No. K2041-1, available from Clontech). The chemical cold counter (Mithras LB 940) was used for the measurement. Chemical luminescence intensity representative of SEAP activity. Figure 4 shows the SEAP activity exhibited by cells after transfection of Sf21 cells with recombinant vectors of vAc-S-Rhir-E, vAc-SEFP or vAc-S-PnV2AI-E, respectively. Intensity. It is clear that the SEAP activity in Sf21 cells transfected with vAc-S-PnV2AI-E is much higher. The SEAP activity in Sf21 cells transfected with vAc-SEFP is approximately 500-fold. Therefore, in vAc The candidate sequence selected in the -S-PnV2AI-E vector can successfully induce ribosomal hopping, avoiding interference defects caused by protein folding in the fusion protein, and does not affect the activity of the target protein. Interestingly, 'with vAc_S The SEAP activity in -PnV2AI-E transfected Sf21 cells was also much higher than in vAc- SEAP activity in Sf21 cells transfected with S-Rhir-E, while in vAc-S-Rhir-E transfected cells, SEAP and EGFP were also expressed as individual proteins. vAc-S-PnV2AI- The SEAP activity in E-transfected Sf21 cells was approximately 100-fold higher than the SEAP activity of 201031757 in Sf21 cells transfected with vAc-S-Rhir-E. The inventors believe that this may be due to a sequence similar to PnV2A. The mRNA is more stable than the mRNA of the RhPV IRES sequence. 2.4 Quantitative Green Fluorescence The amount of EGFP protein on the PVDF membrane can be quantified using a cold light kit (Piece). The results are shown in Figure 5, which shows vAc, respectively. Fluorescence pattern in Sf21 cells after transfection of Sf21 cells with S-Rhir-E, vAc-SEFP or vAc-S, PnV2AI, E recombinant vector. Similarly, p was transfected with vAc-S-PnV2AI-E The EGFP fluorescence intensity in Sf21 cells was much higher than that in Sf21 cells transfected with vAc-SEFP or vAc-S-Rhir-E, respectively. Therefore, it is clear that a similar PnV2A sequence fused to EGFP. The self-cleavage activity does not affect the fluorescence intensity of EGFP. Example 3 Another sequence similar to 2A identified by the method of Example 2 Another ❹2A-like sequence was identified and propagated according to the method disclosed in Example 2. The insect host cells transfected with this sequence also exhibited a donut-shaped fluorescence distribution pattern under a fluorescence microscope, and thus it was confirmed that the identified sequence was a sequence similar to 2A. This sequence was sequenced and found to contain a polynucleotide sequence of SEQ ID NO: 3 and was encoded to produce a multi-peptide comprising the amino acid sequence of SEQ ID NO: 4. Industrial Applicability The present invention utilizes a fluorescence distribution pattern generated by a host cell 20 201031757 to display a desired sequence similar to 2A after collectively exhibiting two protein-secretory proteins and fluorescent proteins in an insect host cell. First, the recombinant vector containing the sequence, the sequence, and the two reporter genes constructed by the method of the present invention is used to transfer the insect-derived primary cells, and then the fluorescent cells in the transformed insect host cells are observed under a fluorescence microscope. The light distribution pattern determines whether the selected candidate sequence is the desired 2A-like sequence. The donut-shaped fluorescence distribution pattern represents that the selected candidate sequence is not the desired 2A-like sequence. Conversely, the fluorescence pattern uniformly distributed within the cell means that the selected candidate sequence is the desired ❿ 2A-like. sequence. Accordingly, the present invention provides a simple and rapid screening method and/or system that can be used to identify sequences similar to 2a having translational level self-cleavage activity. While the invention has been described in detail herein with reference to the embodiments of the present invention, it will be understood that Such changes and modifications shall still be considered as the scope of the following patent application. BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a schematic view showing the structure of a recombinant carrier of (A) VAC-S-Rhir-E, (B) VAOSEFP and (C) vAc-^PnV2AI-E; ! The fluorescent mode photographs of the cells expressed by the three recombinant vectors transfected with Sf21 cells are shown in the figure. Figure 3 shows the Sf2l measured by Western blot analysis. EGFP content in the nucleus; 21 201031757 Figure 4 is a bar graph illustrating the measured SEAP activity after transfection of 'Sf21 cells with the recombinant vector of Figure 1; and the histogram of Figure 5 is shown in Figure 1. The recombinant vector was used to transfect Sf21 cells to express the quantitative results of EGFP. [Main component symbol description] No component symbol

22 201031757 序列表 <110>私立中原大學 國立臺灣大學 <120>用來鑑別具有轉譯層級自我切割活性之多核苷酸的方法舆系統 <130>22 201031757 Sequence Listing <110> Private Chung Yuan University National Taiwan University <120> Method for identifying polynucleotides with translational level self-cleavable activity 舆 system <130>

<160〉 8 <170> Patentln version 3.3 <210> 1 <211> 60 <212> DNA<160〉 8 <170> Patentln version 3.3 <210> 1 <211> 60 <212> DNA

<213> perina nuda Picorna-like virus <400> 1<213> perina nuda Picorna-like virus <400> 1

gcccaggggt gggttccgga. tttgactgtg gatggagatg ttgagtcaaa tccc£gaccc 60 <210> 2 <211> 20 <212> PRT <213> perina nuda Picorna-like virus <400> 2Gcccaggggt gggttccgga. tttgactgtg gatggagatg ttgagtcaaa tccc£gaccc 60 <210> 2 <211> 20 <212> PRT <213> perina nuda Picorna-like virus <400> 2

Ala Gin Gly Trp Val Pro Asp Leu Thr Val Asp Gly Asp Val Glu Ser 1 5 10 15Ala Gin Gly Trp Val Pro Asp Leu Thr Val Asp Gly Asp Val Glu Ser 1 5 10 15

Asn Pro Gly Pro 20Asn Pro Gly Pro 20

<210〉 3 <211> 60 <212> DNA <213> perina nuda Picorna-like virus <400〉 3 attggtggtg ggcagaagga tttgacacaa gatggtgaca tcgagtcgaa tcctgggccc 60 23 201031757 " <210〉 4<210> 3 <211> 60 <212> DNA <213> perina nuda Picorna-like virus <400> 3 attggtggtg ggcagaagga tttgacacaa gatggtgaca tcgagtcgaa tcctgggccc 60 23 201031757 "<210〉 4

<211> 20 ' <212〉 PRT <213> perina nuda Picorna-like virus <400〉 4 lie Gly Gly Gly Gin Lys Asp Leu Thr Gin Asp Gly Asp He Glu Ser 15 10 15<211> 20 ' <212> PRT <213> perina nuda Picorna-like virus <400> 4 lie Gly Gly Gly Gin Lys Asp Leu Thr Gin Asp Gly Asp He Glu Ser 15 10 15

Asn Pro Gly Pro 20Asn Pro Gly Pro 20

<210> 5 <211> 41 <212> DNA <213> Artifical DNA <400> 5 atataagatc tccaccatgc tgctgctgtg ctgctgctgg g 41 <210〉 6 <211> 34 <212> m<210> 5 <211> 41 <212> DNA <213> Artifical DNA <400> 5 atataagatc tccaccatgc tgctgctgtg ctgctgctgg g 41 <210> 6 <211> 34 <212> m

<213〉 Artifical DNA<213〉 Artifical DNA

<400〉 6 aattcagatc tggtgtctgc tcgaagcggc cggc 34<400〉 6 aattcagatc tggtgtctgc tcgaagcggc cggc 34

<210> 7 <211> 38 <212〉 DNA <213〉 artifical DNA <400〉 7 aatggatccg ctagcccacc atgctgctgc tgctgctg<210> 7 <211> 38 <212> DNA <213> artifical DNA <400> 7 aatggatccg ctagcccacc atgctgctgc tgctgctg

<210〉 8 <211〉 90 <212〉 DNA 24 38 201031757<210〉 8 <211〉 90 <212〉 DNA 24 38 201031757

<213> artifical DNA • <400> 8 aatagatcta agggtccggg gatttgactc aacatctcca tccacagtca aatccggaac ccacccctgg gctgtctgct cgaagcggcc<213> artifical DNA • <400> 8 aatagatcta agggtccggg gatttgactc aacatctcca tccacagtca aatccggaac ccacccctgg gctgtctgct cgaagcggcc

Claims (1)

201031757 七、申請專利範圍: 1. 一種用來在一昆蟲系統中鑑別出一類2A 序列的方法,包含: (a)以一重組載體來轉染一昆蟲細胞,其 組載體包含以下序列: 一啟動子; 一第一多核苷酸’其係可操作地連結到該啟動 子並編碼產生一分泌性蛋白; 一候選序列,其係可操作地連結到該第一 φ 苷酸;及 一第二多核苷酸,其係可操作地連結到該候選 序列並編碼產生一螢光蛋白;和 (b)依據該昆蟲細胞所表現出來的一螢光模式來 決定該候選序列是否具有一轉譯層級自我切割活 性,如果螢光是均勻地分佈在該昆蟲細胞内(包括細 胞核)’則該候選序列是該類似_2A序列;如果螢光 呈現一甜甜圈形狀且侷限在細胞核外或是被分泌到 細胞外介質中,則該候選序列不是該類似_2A序列。 2.如申請專利範圍第1項所述之方法,其中該 候選序列是分離自榕樹透翅毒蛾類小病毒(Perina nuda Picoma-like virus, PnV)且包含一序列編號:1 或3之多核苷酸。 3·如申請專利範圍第2項所述之方法,其中該 候選序列可編碼產生一多胜肽,該多胜肽包含一序 列編號·· 2或4之胺基酸序列,其包括一位在甘氨 26 201031757 酸與脯胺酸之間的轉譯層級自我切割位置。 4.如申請專利範圍第3項 候選序列的轉譯層級自斤达之方法,其中該 锷弄增級自我切割活性高達 該 的比例產 八Cl請專利範圍第4項所述之方法,立中 刀4性蛋白和該螢光蛋白是以大約丨· ' 生。 ❹ 6.如申請專利範圍第1項所述之方法,其中該 昆蟲細胞疋秋行軍蟲(&amp;介叹化〜心)iPBL-sf21細 胞0 7. 如申請專利範圍第1項所述之方法,其中該 分泌性蛋白是分泌性鹼性磷酸酶(SEap)。 8. 如申請專利範圍第1項所述之方法,其中該 螢光蛋白是增強綠螢光蛋白(EGFP)。 9. 一種用來鐘別出一具有轉譯層級自我切割 活性之類似-2A序列的昆蟲系統,包含: 一昆蟲細胞,其被一重組載體轉染,該重組載體 包含下列序列: 一 _啟動.子; 一第一多核苷酸,其係可操作地連結到該啟動子 並編瑪產生一分泌性蛋白; 一候選序列,其係可操作地連結到讓第一多核普 酸;及 27 201031757 列^第核普酸,其係可操作地連結到該候選序 歹j並編碼產生一螢光蛋白;和 昆蟲細胞所表現出來的—螢光模式來決定 ,候選序列是否是該類似_2A序列,如果營光是均 1 佈在該昆蟲細胞内(包括細胞核),則該候選 1列疋該類似-2A序列;如果榮光呈現一甜甜圈形 狀且侷限在細胞核外或是被分泌到細胞外介質中, 則該候選序列不是該類似_2a序列。201031757 VII. Scope of Application: 1. A method for identifying a class of 2A sequences in an insect system comprising: (a) transfecting an insect cell with a recombinant vector comprising the following sequences: a first polynucleotide operably linked to the promoter and encoding to produce a secreted protein; a candidate sequence operably linked to the first φ-nucleotide; and a second a polynucleotide operably linked to the candidate sequence and encoding to produce a fluorescent protein; and (b) determining whether the candidate sequence has a translational level self based on a fluorescent pattern exhibited by the insect cell Cleavage activity, if the fluorescence is evenly distributed within the insect cell (including the nucleus), then the candidate sequence is the similar _2A sequence; if the fluorescence is in the shape of a donut and is confined to the nucleus or secreted to In an extracellular medium, the candidate sequence is not the similar _2A sequence. 2. The method of claim 1, wherein the candidate sequence is a nucleoside isolated from a Perina nuda Picoma-like virus (PnV) and comprising a SEQ ID NO: 1 or 3. acid. 3. The method of claim 2, wherein the candidate sequence encodes a multi-peptide comprising a sequence of amino acid sequences of number 2 or 4, including one Glycine 26 201031757 Translational level self-cutting position between acid and proline. 4. The method for translating the level of the candidate sequence of the third candidate sequence of the patent application, wherein the self-cutting activity of the cockroach is up to the ratio of the production of the eighth liter, the method described in item 4 of the patent scope, Lizhong knife The 4-sex protein and the fluorescent protein are approximately 丨·'. ❹ 6. The method of claim 1, wherein the insect cell 疋 行 军 ( (&amp; 叹 化 ~ heart) iPBL-sf21 cells 0 7. The method of claim 1 Wherein the secreted protein is secreted alkaline phosphatase (SEap). 8. The method of claim 1, wherein the fluorescent protein is enhanced green fluorescent protein (EGFP). 9. An insect system for identifying a similar-2A sequence having a translational level of self-cleavage activity, comprising: an insect cell transfected with a recombinant vector comprising the following sequences: a first polynucleotide operably linked to the promoter and transcribed to produce a secreted protein; a candidate sequence operably linked to the first polynucleotide; and 27 201031757 a nucleotide, which is operably linked to the candidate sequence and encoded to produce a fluorescent protein; and a fluorescent pattern exhibited by the insect cell to determine whether the candidate sequence is the similar _2A sequence If the camp light is uniformly distributed within the insect cell (including the nucleus), then the candidate 1 column is similar to the -2A sequence; if the glory presents a donut shape and is confined to the nucleus or secreted outside the cell In the medium, the candidate sequence is not the similar _2a sequence. 〗0.如申請專利範圍第9項所述之系統,其中該 候選序列是分離自榕樹透翅毒峨類小病毒(perina nuda Plcoma_like virus,pnv)且包含一序列編號:t 或3之多核苷酸。 11.如申請專利範圍第1〇項所述之系統,其中該 候選序列可編碼產生一多胜肽,該多胜肽包含一序 列編號:2或4之胺基酸序列’其包括一位在甘氨 酸與脯胺酸之間的轉譯層級自我切割位置。 12·如申請專利範圍第丨〗項所述之系統其中該 候選序列的轉譯層級自我切割活性高達1〇〇%。 13.如申請專利範圍第12項所述之系統,其中該 分泌性蛋白和該螢光蛋白是以大約1 : 1的比例產 生0 田14.如申請專利範圍第9項所述之系統,其中該 λ蟲細胞疋秋行軍蟲(S如)IpBL_sf2l細 28 201031757 胞0 1 5.如申請專利範圍第9項所述之系統,其中該 分泌性蛋白是分泌性驗性填酸酶(SΕΑΡ)。 16.如申請專利範圍第9項所述之系統,其中該 螢光蛋白是增強綠螢光蛋白(EGFP)。The system of claim 9, wherein the candidate sequence is a nucleoside isolated from a perina nuda Plcoma_like virus (pnv) and comprising a sequence number: t or 3. acid. 11. The system of claim 1, wherein the candidate sequence encodes a multi-peptide comprising a sequence number: 2 or 4 amino acid sequence comprising one bit Translational level self-cutting position between glycine and valine. 12. The system of claim </ RTI> wherein the candidate sequence has a translation level self-cleaving activity of up to 1%. 13. The system of claim 12, wherein the secretory protein and the fluorescent protein are produced in a ratio of about 1:1. The system of claim 9, wherein the system of claim 9 is wherein The λ worm cell 疋 行 行 ( S S S 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010. 16. The system of claim 9, wherein the fluorescent protein is enhanced green fluorescent protein (EGFP). 2929
TW098105161A 2009-02-18 2009-02-18 Methods and systems for identifying polynucleotide sequences with translational self-cleavage activity TWI412594B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW098105161A TWI412594B (en) 2009-02-18 2009-02-18 Methods and systems for identifying polynucleotide sequences with translational self-cleavage activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW098105161A TWI412594B (en) 2009-02-18 2009-02-18 Methods and systems for identifying polynucleotide sequences with translational self-cleavage activity

Publications (2)

Publication Number Publication Date
TW201031757A true TW201031757A (en) 2010-09-01
TWI412594B TWI412594B (en) 2013-10-21

Family

ID=44854614

Family Applications (1)

Application Number Title Priority Date Filing Date
TW098105161A TWI412594B (en) 2009-02-18 2009-02-18 Methods and systems for identifying polynucleotide sequences with translational self-cleavage activity

Country Status (1)

Country Link
TW (1) TWI412594B (en)

Also Published As

Publication number Publication date
TWI412594B (en) 2013-10-21

Similar Documents

Publication Publication Date Title
US11198864B2 (en) Protease-resistant systems for polypeptide display and methods of making and using thereof
US10626416B2 (en) Nucleic acid-guided nucleases
US9982279B1 (en) Nucleic acid-guided nucleases
Dubin et al. A versatile set of tagged expression vectors to monitor protein localisation and function in Dictyostelium
JP7054527B2 (en) High-throughput assay to measure adenovirus replication kinetics
JP2007513602A5 (en) Expression vectors, polypeptide display libraries, and methods for their production and use
Snider et al. Split-ubiquitin based membrane yeast two-hybrid (MYTH) system: a powerful tool for identifying protein-protein interactions
JP2009513141A5 (en)
CN104991072A (en) Manufacturing method and application of insect in-vitro protein interaction detecting system
Gross et al. Insertion of plastidic β-barrel proteins into the outer envelopes of plastids involves an intermembrane space intermediate formed with Toc75-V/OEP80
TWI300441B (en) A polynucleotide with ires activity
JP2004537313A (en) Method for detecting protease activity in cells
US20100216191A1 (en) Method for Manufacturing a Modified Peptide
JP6667897B2 (en) Polypeptides exhibiting fluorescent properties and uses thereof
JP2005519620A (en) Genetically engineered baculovirus and use thereof
TW201031757A (en) Methods and systems for identifying polynucleotide sequences with translational self-cleavage activity
US8586315B2 (en) Fluorescent protein particles
CN111718929B (en) Protein translation using circular RNA and uses thereof
JP5036741B2 (en) Method and system for identifying polynucleotide sequences having self-cleaving activity at the translation stage
JP2003525605A (en) Green fluorescent protein of Renilla reniformis and its mutants
KR20200137596A (en) Composition for diagnosis acute kidney transplant rejection reaction and diagnostic kit containing the same
US20100209910A1 (en) Methods and systems for identifying polynucleotide sequences with translational self-cleavage activity
JP2008182905A (en) Method for producing human prorenin receptor, method for screening human prorenin receptor blocker, method for measuring prorenin concentration and anti-human prorenin receptor antibody
JP2024517633A (en) Novel luciferases with improved properties
KR101104817B1 (en) The use of esterase ESTL120P for reporter as a fusion partner, and its use for indicator in cloning vector system

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees